Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
7001
7002
7003
7004
7005
7006
7007
7008
7009
7010
7011
7012
7013
7014
7015
7016
7017
7018
7019
7020
7021
7022
7023
7024
7025
7026
7027
7028
7029
7030
7031
7032
7033
7034
7035
7036
7037
7038
7039
7040
7041
7042
7043
7044
7045
7046
7047
7048
7049
7050
7051
7052
7053
7054
7055
7056
7057
7058
7059
7060
7061
7062
7063
7064
7065
7066
7067
7068
7069
7070
7071
7072
7073
7074
7075
7076
7077
7078
7079
7080
7081
7082
7083
7084
7085
7086
7087
7088
7089
7090
7091
7092
7093
7094
7095
7096
7097
7098
7099
7100
7101
7102
7103
7104
7105
7106
7107
7108
7109
7110
7111
7112
7113
7114
7115
7116
7117
7118
7119
7120
7121
7122
7123
7124
7125
7126
7127
7128
7129
7130
7131
7132
7133
7134
7135
7136
7137
7138
7139
7140
7141
7142
7143
7144
7145
7146
7147
7148
7149
7150
7151
7152
7153
7154
7155
7156
7157
7158
7159
7160
7161
7162
7163
7164
7165
7166
7167
7168
7169
7170
7171
7172
7173
7174
7175
7176
7177
7178
7179
7180
7181
7182
7183
7184
7185
7186
7187
7188
7189
7190
7191
7192
7193
7194
7195
7196
7197
7198
7199
7200
| UnnamedSample_HQ_transcript/65896|m.17185 | UnnamedSample_HQ_transcript/65896 | Identity 0.695 too low. | e295243a56236e2080b8818ff23876d8 | 423 | Pfam | PF03619 | Organic solute transporter Ostalpha | 121 | 381 | 7.8E-34 | T | 22-09-2020 | IPR005178 | Organic solute transporter subunit alpha/Transmembrane protein 184 |
| UnnamedSample_HQ_transcript/94053|m.21810 | UnnamedSample_HQ_transcript/94053 | Coverage 0.410 too low. | 2d9cfac27aa18f78f726189f5c541079 | 233 | Pfam | PF05644 | Mitochondrial and peroxisomal fission factor Mff | 180 | 231 | 1.0E-10 | T | 22-09-2020 | IPR039433 | Mff-like domain |
| UnnamedSample_HQ_transcript/94053|m.21810 | UnnamedSample_HQ_transcript/94053 | Coverage 0.410 too low. | 2d9cfac27aa18f78f726189f5c541079 | 233 | Pfam | PF05644 | Mitochondrial and peroxisomal fission factor Mff | 15 | 179 | 4.9E-33 | T | 22-09-2020 | IPR039433 | Mff-like domain |
| UnnamedSample_HQ_transcript/46155|m.13177 | UnnamedSample_HQ_transcript/46155 | Identity 0.948 too low. | df88cec776a01c4d24039ac83ad9e3c9 | 715 | Pfam | PF03725 | 3' exoribonuclease family, domain 2 | 186 | 250 | 2.0E-13 | T | 22-09-2020 | IPR015847 | Exoribonuclease, phosphorolytic domain 2 |
| UnnamedSample_HQ_transcript/46155|m.13177 | UnnamedSample_HQ_transcript/46155 | Identity 0.948 too low. | df88cec776a01c4d24039ac83ad9e3c9 | 715 | Pfam | PF03726 | Polyribonucleotide nucleotidyltransferase, RNA binding domain | 282 | 363 | 1.4E-9 | T | 22-09-2020 | IPR015848 | Polyribonucleotide nucleotidyltransferase, RNA-binding domain |
| UnnamedSample_HQ_transcript/46155|m.13177 | UnnamedSample_HQ_transcript/46155 | Identity 0.948 too low. | df88cec776a01c4d24039ac83ad9e3c9 | 715 | Pfam | PF01138 | 3' exoribonuclease family, domain 1 | 367 | 502 | 5.6E-22 | T | 22-09-2020 | IPR001247 | Exoribonuclease, phosphorolytic domain 1 |
| UnnamedSample_HQ_transcript/46155|m.13177 | UnnamedSample_HQ_transcript/46155 | Identity 0.948 too low. | df88cec776a01c4d24039ac83ad9e3c9 | 715 | Pfam | PF01138 | 3' exoribonuclease family, domain 1 | 57 | 183 | 1.6E-12 | T | 22-09-2020 | IPR001247 | Exoribonuclease, phosphorolytic domain 1 |
| UnnamedSample_HQ_transcript/46155|m.13177 | UnnamedSample_HQ_transcript/46155 | Identity 0.948 too low. | df88cec776a01c4d24039ac83ad9e3c9 | 715 | Pfam | PF00013 | KH domain | 611 | 667 | 5.4E-6 | T | 22-09-2020 | IPR004088 | K Homology domain, type 1 |
| UnnamedSample_HQ_transcript/117056|m.24589 | UnnamedSample_HQ_transcript/117056 | Coverage 0.981 too low. | 136d526d977c6739c088c9f98985df59 | 154 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 2 | 154 | 4.6E-50 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/27117|m.8751 | UnnamedSample_HQ_transcript/27117 | Coverage 0.980 too low. | 53270c4171c48df8741876192a3fc51c | 864 | Pfam | PF03165 | MH1 domain | 28 | 129 | 1.3E-19 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/115817|m.24473 | UnnamedSample_HQ_transcript/115817 | Coverage 0.433 too low. | 8c284761fe00721ee444ad684c310c1d | 174 | Pfam | PF10259 | Rogdi leucine zipper containing protein | 20 | 171 | 1.7E-15 | T | 22-09-2020 | IPR028241 | RAVE subunit 2/Rogdi |
| UnnamedSample_HQ_transcript/117677|m.24653 | UnnamedSample_HQ_transcript/117677 | Unmapped. | 109ce95583dfb94e17e51b5671409fae | 221 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 96 | 166 | 8.8E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/2651|m.1299 | UnnamedSample_HQ_transcript/2651 | Coverage 0.759 too low. | 1ae6a22de91a4f7f1500f6a4dbf0d593 | 1731 | Pfam | PF00498 | FHA domain | 428 | 485 | 3.6E-6 | T | 22-09-2020 | IPR000253 | Forkhead-associated (FHA) domain |
| UnnamedSample_HQ_transcript/2651|m.1299 | UnnamedSample_HQ_transcript/2651 | Coverage 0.759 too low. | 1ae6a22de91a4f7f1500f6a4dbf0d593 | 1731 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 239 | 349 | 1.2E-20 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/2651|m.1299 | UnnamedSample_HQ_transcript/2651 | Coverage 0.759 too low. | 1ae6a22de91a4f7f1500f6a4dbf0d593 | 1731 | Pfam | PF00788 | Ras association (RalGDS/AF-6) domain | 45 | 136 | 3.2E-19 | T | 22-09-2020 | IPR000159 | Ras-associating (RA) domain |
| UnnamedSample_HQ_transcript/2651|m.1299 | UnnamedSample_HQ_transcript/2651 | Coverage 0.759 too low. | 1ae6a22de91a4f7f1500f6a4dbf0d593 | 1731 | Pfam | PF00595 | PDZ domain | 1043 | 1123 | 9.0E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/2651|m.1299 | UnnamedSample_HQ_transcript/2651 | Coverage 0.759 too low. | 1ae6a22de91a4f7f1500f6a4dbf0d593 | 1731 | Pfam | PF01843 | DIL domain | 813 | 915 | 3.0E-30 | T | 22-09-2020 | IPR002710 | Dilute domain |
| UnnamedSample_HQ_transcript/81609|m.19970 | UnnamedSample_HQ_transcript/81609 | Identity 0.940 too low. | f636af50f72212c0c547ccd14a83b0fe | 273 | Pfam | PF03134 | TB2/DP1, HVA22 family | 19 | 96 | 2.2E-24 | T | 22-09-2020 | IPR004345 | TB2/DP1/HVA22-related protein |
| UnnamedSample_HQ_transcript/84917|m.20485 | UnnamedSample_HQ_transcript/84917 | Coverage 0.772 too low. | 794d6c3d5e603109fbc7a54e20cb3941 | 366 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 2.3E-27 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/84917|m.20485 | UnnamedSample_HQ_transcript/84917 | Coverage 0.772 too low. | 794d6c3d5e603109fbc7a54e20cb3941 | 366 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 8.2E-21 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/70628|m.18039 | UnnamedSample_HQ_transcript/70628 | Identity 0.903 too low. | d30cffd0deb491dccb5cdaf1ef0a2a8e | 521 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 42 | 514 | 9.0E-81 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/62482|m.16537 | UnnamedSample_HQ_transcript/62482 | Identity 0.911 too low. | d30cffd0deb491dccb5cdaf1ef0a2a8e | 521 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 42 | 514 | 9.0E-81 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/78602|m.19481 | UnnamedSample_HQ_transcript/78602 | Identity 0.897 too low. | d30cffd0deb491dccb5cdaf1ef0a2a8e | 521 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 42 | 514 | 9.0E-81 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/7215|m.2926 | UnnamedSample_HQ_transcript/7215 | Coverage 0.644 too low. | 348ac9e9c90f91a6928fa8bdf017e619 | 989 | Pfam | PF00999 | Sodium/hydrogen exchanger family | 117 | 517 | 8.9E-87 | T | 22-09-2020 | IPR006153 | Cation/H+ exchanger |
| UnnamedSample_HQ_transcript/25942|m.8463 | UnnamedSample_HQ_transcript/25942 | Coverage 0.896 too low. | c44bb4a55ca919d8cdc0eef8742c0bd0 | 941 | Pfam | PF00240 | Ubiquitin family | 4 | 73 | 4.4E-17 | T | 22-09-2020 | IPR000626 | Ubiquitin-like domain |
| UnnamedSample_HQ_transcript/25942|m.8463 | UnnamedSample_HQ_transcript/25942 | Coverage 0.896 too low. | c44bb4a55ca919d8cdc0eef8742c0bd0 | 941 | Pfam | PF12057 | BCL2-associated athanogene 6 | 275 | 366 | 3.9E-20 | T | 22-09-2020 | IPR021925 | Large proline-rich protein BAG6 |
| UnnamedSample_HQ_transcript/49102|m.13829 | UnnamedSample_HQ_transcript/49102 | Identity 0.873 too low. | 4d9521bd488b8c33bb41e73ee5c6369e | 403 | Pfam | PF07690 | Major Facilitator Superfamily | 62 | 387 | 1.4E-42 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/71027|m.18116 | UnnamedSample_HQ_transcript/71027 | Coverage 0.694 too low. | b1fd5ce62834901633cad889204d0d61 | 285 | Pfam | PF00089 | Trypsin | 201 | 276 | 1.4E-11 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/71027|m.18116 | UnnamedSample_HQ_transcript/71027 | Coverage 0.694 too low. | b1fd5ce62834901633cad889204d0d61 | 285 | Pfam | PF16030 | Serine protease gd N-terminus | 24 | 130 | 1.9E-16 | T | 22-09-2020 | IPR031986 | Serine protease gd, N-terminal domain |
| UnnamedSample_HQ_transcript/55056|m.15051 | UnnamedSample_HQ_transcript/55056 | Coverage 0.916 too low. | 7f3d0fcf0b660fc70eaf7db5f6d7fffb | 483 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 53 | 377 | 6.1E-74 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/20634|m.7045 | UnnamedSample_HQ_transcript/20634 | Coverage 0.161 too low. | 4d5b944d4f792da4a60c2c2a0ad996db | 557 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 272 | 343 | 1.3E-9 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/20634|m.7045 | UnnamedSample_HQ_transcript/20634 | Coverage 0.161 too low. | 4d5b944d4f792da4a60c2c2a0ad996db | 557 | Pfam | PF13927 | Immunoglobulin domain | 173 | 242 | 1.7E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20634|m.7045 | UnnamedSample_HQ_transcript/20634 | Coverage 0.161 too low. | 4d5b944d4f792da4a60c2c2a0ad996db | 557 | Pfam | PF13927 | Immunoglobulin domain | 370 | 439 | 8.9E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20634|m.7045 | UnnamedSample_HQ_transcript/20634 | Coverage 0.161 too low. | 4d5b944d4f792da4a60c2c2a0ad996db | 557 | Pfam | PF07686 | Immunoglobulin V-set domain | 45 | 152 | 5.5E-11 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/23798|m.7891 | UnnamedSample_HQ_transcript/23798 | Coverage 0.668 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF13927 | Immunoglobulin domain | 447 | 524 | 2.5E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/23798|m.7891 | UnnamedSample_HQ_transcript/23798 | Coverage 0.668 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07686 | Immunoglobulin V-set domain | 51 | 161 | 2.3E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/23798|m.7891 | UnnamedSample_HQ_transcript/23798 | Coverage 0.668 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF00041 | Fibronectin type III domain | 666 | 744 | 1.3E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/23798|m.7891 | UnnamedSample_HQ_transcript/23798 | Coverage 0.668 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF00041 | Fibronectin type III domain | 544 | 627 | 1.7E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/23798|m.7891 | UnnamedSample_HQ_transcript/23798 | Coverage 0.668 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07679 | Immunoglobulin I-set domain | 259 | 342 | 1.2E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/23798|m.7891 | UnnamedSample_HQ_transcript/23798 | Coverage 0.668 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07679 | Immunoglobulin I-set domain | 166 | 253 | 2.6E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2992|m.1439 | UnnamedSample_HQ_transcript/2992 | Coverage 0.784 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF13927 | Immunoglobulin domain | 447 | 524 | 2.5E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/2992|m.1439 | UnnamedSample_HQ_transcript/2992 | Coverage 0.784 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07686 | Immunoglobulin V-set domain | 51 | 161 | 2.3E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/2992|m.1439 | UnnamedSample_HQ_transcript/2992 | Coverage 0.784 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF00041 | Fibronectin type III domain | 666 | 744 | 1.3E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2992|m.1439 | UnnamedSample_HQ_transcript/2992 | Coverage 0.784 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF00041 | Fibronectin type III domain | 544 | 627 | 1.7E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/2992|m.1439 | UnnamedSample_HQ_transcript/2992 | Coverage 0.784 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07679 | Immunoglobulin I-set domain | 259 | 342 | 1.2E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/2992|m.1439 | UnnamedSample_HQ_transcript/2992 | Coverage 0.784 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07679 | Immunoglobulin I-set domain | 166 | 253 | 2.6E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/22553|m.7585 | UnnamedSample_HQ_transcript/22553 | Coverage 0.655 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF13927 | Immunoglobulin domain | 447 | 524 | 2.5E-11 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/22553|m.7585 | UnnamedSample_HQ_transcript/22553 | Coverage 0.655 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07686 | Immunoglobulin V-set domain | 51 | 161 | 2.3E-8 | T | 22-09-2020 | IPR013106 | Immunoglobulin V-set domain |
| UnnamedSample_HQ_transcript/22553|m.7585 | UnnamedSample_HQ_transcript/22553 | Coverage 0.655 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF00041 | Fibronectin type III domain | 666 | 744 | 1.3E-7 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/22553|m.7585 | UnnamedSample_HQ_transcript/22553 | Coverage 0.655 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF00041 | Fibronectin type III domain | 544 | 627 | 1.7E-6 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/22553|m.7585 | UnnamedSample_HQ_transcript/22553 | Coverage 0.655 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07679 | Immunoglobulin I-set domain | 259 | 342 | 1.2E-13 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/22553|m.7585 | UnnamedSample_HQ_transcript/22553 | Coverage 0.655 too low. | 2930eec5085fc6812ad13151851210c4 | 843 | Pfam | PF07679 | Immunoglobulin I-set domain | 166 | 253 | 2.6E-16 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/63706|m.16775 | UnnamedSample_HQ_transcript/63706 | Coverage 0.939 too low. | 8dbe1d6f78d77c60e69ec21aadb2abf1 | 226 | Pfam | PF00373 | FERM central domain | 12 | 120 | 4.5E-16 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/72296|m.18351 | UnnamedSample_HQ_transcript/72296 | Coverage 0.987 too low. | 90bf52c7073e61ec931c2a020c3335c3 | 468 | Pfam | PF00083 | Sugar (and other) transporter | 18 | 447 | 1.7E-50 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/69209|m.17796 | UnnamedSample_HQ_transcript/69209 | Coverage 0.739 too low. | f25983b423c1c4a4507d78222dcd789f | 502 | Pfam | PF04666 | N-Acetylglucosaminyltransferase-IV (GnT-IV) conserved region | 52 | 341 | 8.0E-116 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/86720|m.20760 | UnnamedSample_HQ_transcript/86720 | Coverage 0.707 too low. | 5d1390f88103658baa73eaacf2ba8faa | 337 | Pfam | PF00083 | Sugar (and other) transporter | 65 | 326 | 7.5E-37 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/11069|m.4171 | UnnamedSample_HQ_transcript/11069 | Coverage 0.757 too low. | 825ecd219082a105c9c868c0f66511fc | 1020 | Pfam | PF00046 | Homeodomain | 678 | 733 | 7.8E-14 | T | 22-09-2020 | IPR001356 | Homeobox domain |
| UnnamedSample_HQ_transcript/11069|m.4171 | UnnamedSample_HQ_transcript/11069 | Coverage 0.757 too low. | 825ecd219082a105c9c868c0f66511fc | 1020 | Pfam | PF13894 | C2H2-type zinc finger | 259 | 280 | 5.1E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11069|m.4171 | UnnamedSample_HQ_transcript/11069 | Coverage 0.757 too low. | 825ecd219082a105c9c868c0f66511fc | 1020 | Pfam | PF00096 | Zinc finger, C2H2 type | 317 | 337 | 0.0057 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/11069|m.4171 | UnnamedSample_HQ_transcript/11069 | Coverage 0.757 too low. | 825ecd219082a105c9c868c0f66511fc | 1020 | Pfam | PF00096 | Zinc finger, C2H2 type | 289 | 311 | 5.9E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/11069|m.4171 | UnnamedSample_HQ_transcript/11069 | Coverage 0.757 too low. | 825ecd219082a105c9c868c0f66511fc | 1020 | Pfam | PF00096 | Zinc finger, C2H2 type | 933 | 955 | 0.0039 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/44571|m.12830 | UnnamedSample_HQ_transcript/44571 | Coverage 0.066 too low. | c008ae2f682c899126d976dab222dbee | 355 | Pfam | PF00170 | bZIP transcription factor | 102 | 163 | 5.2E-15 | T | 22-09-2020 | IPR004827 | Basic-leucine zipper domain |
| UnnamedSample_HQ_transcript/75749|m.18978 | UnnamedSample_HQ_transcript/75749 | Coverage 0.973 too low. | b7dfa7eda1791fd226bf9e871f970db4 | 449 | Pfam | PF04116 | Fatty acid hydroxylase superfamily | 109 | 239 | 3.2E-25 | T | 22-09-2020 | IPR006694 | Fatty acid hydroxylase |
| UnnamedSample_HQ_transcript/41350|m.12128 | UnnamedSample_HQ_transcript/41350 | Coverage 0.605 too low. | 0141d0d7d98eff376c8faf447dd9756b | 649 | Pfam | PF02181 | Formin Homology 2 Domain | 34 | 417 | 1.5E-86 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/51491|m.14350 | UnnamedSample_HQ_transcript/51491 | Coverage 0.680 too low. | 0141d0d7d98eff376c8faf447dd9756b | 649 | Pfam | PF02181 | Formin Homology 2 Domain | 34 | 417 | 1.5E-86 | T | 22-09-2020 | IPR015425 | Formin, FH2 domain |
| UnnamedSample_HQ_transcript/89876|m.21233 | UnnamedSample_HQ_transcript/89876 | Coverage 0.150 too low. | b3769469b52c189cb3e3c32d7ee0e34c | 388 | Pfam | PF00620 | RhoGAP domain | 160 | 296 | 2.5E-32 | T | 22-09-2020 | IPR000198 | Rho GTPase-activating protein domain |
| UnnamedSample_HQ_transcript/57536|m.15554 | UnnamedSample_HQ_transcript/57536 | Coverage 0.391 too low. | 51315d88091194e4341cc292b61789bb | 277 | Pfam | PF06775 | Putative adipose-regulatory protein (Seipin) | 53 | 250 | 1.2E-58 | T | 22-09-2020 | IPR009617 | Seipin family |
| UnnamedSample_HQ_transcript/24735|m.8146 | UnnamedSample_HQ_transcript/24735 | Coverage 0.880 too low. | 5e84e72c4d5caf671f77ff89cdff5073 | 665 | Pfam | PF13927 | Immunoglobulin domain | 120 | 232 | 4.1E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24735|m.8146 | UnnamedSample_HQ_transcript/24735 | Coverage 0.880 too low. | 5e84e72c4d5caf671f77ff89cdff5073 | 665 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 542 | 641 | 6.6E-16 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/7159|m.2913 | UnnamedSample_HQ_transcript/7159 | Coverage 0.635 too low. | 87a2c27ba1d754587921c6f97106b982 | 468 | Pfam | PF02149 | Kinase associated domain 1 | 426 | 468 | 1.7E-19 | T | 22-09-2020 | IPR001772 | Kinase associated domain 1 (KA1) |
| UnnamedSample_HQ_transcript/16318|m.5803 | UnnamedSample_HQ_transcript/16318 | Coverage 0.911 too low. | ee079a20ef767ca849f7acfe60319421 | 695 | Pfam | PF00168 | C2 domain | 105 | 211 | 3.0E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/13190|m.4865 | UnnamedSample_HQ_transcript/13190 | Coverage 0.899 too low. | ee079a20ef767ca849f7acfe60319421 | 695 | Pfam | PF00168 | C2 domain | 105 | 211 | 3.0E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/88495|m.21019 | UnnamedSample_HQ_transcript/88495 | Coverage 0.805 too low. | 1acb4760350996bd3ac6b1990587d0a4 | 309 | Pfam | PF02932 | Neurotransmitter-gated ion-channel transmembrane region | 103 | 299 | 2.7E-27 | T | 22-09-2020 | IPR006029 | Neurotransmitter-gated ion-channel transmembrane domain |
| UnnamedSample_HQ_transcript/88495|m.21019 | UnnamedSample_HQ_transcript/88495 | Coverage 0.805 too low. | 1acb4760350996bd3ac6b1990587d0a4 | 309 | Pfam | PF02931 | Neurotransmitter-gated ion-channel ligand binding domain | 1 | 68 | 2.8E-13 | T | 22-09-2020 | IPR006202 | Neurotransmitter-gated ion-channel ligand-binding domain |
| UnnamedSample_HQ_transcript/18425|m.6427 | UnnamedSample_HQ_transcript/18425 | Identity 0.794 too low. | cc59bcd1b7e213ab1c6484c6fa5d3dac | 464 | Pfam | PF09334 | tRNA synthetases class I (M) | 258 | 342 | 1.8E-9 | T | 22-09-2020 | IPR015413 | Methionyl/Leucyl tRNA synthetase |
| UnnamedSample_HQ_transcript/50670|m.14168 | UnnamedSample_HQ_transcript/50670 | Coverage 0.618 too low. | 86fba768fc7fc57d53edc448912dc8ee | 561 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 2.2E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/15496|m.5550 | UnnamedSample_HQ_transcript/15496 | Coverage 0.752 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 172 | 254 | 2.5E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/15496|m.5550 | UnnamedSample_HQ_transcript/15496 | Coverage 0.752 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 673 | 745 | 1.0E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/15496|m.5550 | UnnamedSample_HQ_transcript/15496 | Coverage 0.752 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 298 | 368 | 1.6E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/15496|m.5550 | UnnamedSample_HQ_transcript/15496 | Coverage 0.752 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 839 | 918 | 1.5E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/15496|m.5550 | UnnamedSample_HQ_transcript/15496 | Coverage 0.752 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 477 | 552 | 5.4E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/7686|m.3084 | UnnamedSample_HQ_transcript/7686 | Coverage 0.829 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 172 | 254 | 2.5E-16 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/7686|m.3084 | UnnamedSample_HQ_transcript/7686 | Coverage 0.829 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 673 | 745 | 1.0E-7 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/7686|m.3084 | UnnamedSample_HQ_transcript/7686 | Coverage 0.829 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 298 | 368 | 1.6E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/7686|m.3084 | UnnamedSample_HQ_transcript/7686 | Coverage 0.829 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 839 | 918 | 1.5E-12 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/7686|m.3084 | UnnamedSample_HQ_transcript/7686 | Coverage 0.829 too low. | 2f4fa6f07109bfcfb208c2b479d4b9cc | 935 | Pfam | PF00595 | PDZ domain | 477 | 552 | 5.4E-13 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/28260|m.9033 | UnnamedSample_HQ_transcript/28260 | Identity 0.843 too low. | 706712e62da7fe184e0cf7d49073024c | 786 | Pfam | PF01429 | Methyl-CpG binding domain | 58 | 120 | 6.3E-8 | T | 22-09-2020 | IPR001739 | Methyl-CpG DNA binding |
| UnnamedSample_HQ_transcript/82814|m.20161 | UnnamedSample_HQ_transcript/82814 | Identity 0.920 too low. | 4c37c60630055c455e4802ce22e42889 | 276 | Pfam | PF13640 | 2OG-Fe(II) oxygenase superfamily | 148 | 241 | 2.3E-21 | T | 22-09-2020 | IPR005123 | Oxoglutarate/iron-dependent dioxygenase |
| UnnamedSample_HQ_transcript/39785|m.11810 | UnnamedSample_HQ_transcript/39785 | Identity 0.870 too low. | 683573f1c951c3aba55a41f5879d0e9f | 521 | Pfam | PF00012 | Hsp70 protein | 1 | 394 | 9.0E-65 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/58778|m.15810 | UnnamedSample_HQ_transcript/58778 | Identity 0.933 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/58778|m.15810 | UnnamedSample_HQ_transcript/58778 | Identity 0.933 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/60587|m.16177 | UnnamedSample_HQ_transcript/60587 | Identity 0.933 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/60587|m.16177 | UnnamedSample_HQ_transcript/60587 | Identity 0.933 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/40284|m.11904 | UnnamedSample_HQ_transcript/40284 | Identity 0.943 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/40284|m.11904 | UnnamedSample_HQ_transcript/40284 | Identity 0.943 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/50113|m.14046 | UnnamedSample_HQ_transcript/50113 | Identity 0.938 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/50113|m.14046 | UnnamedSample_HQ_transcript/50113 | Identity 0.938 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/53209|m.14684 | UnnamedSample_HQ_transcript/53209 | Identity 0.936 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/53209|m.14684 | UnnamedSample_HQ_transcript/53209 | Identity 0.936 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/52746|m.14592 | UnnamedSample_HQ_transcript/52746 | Identity 0.936 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/52746|m.14592 | UnnamedSample_HQ_transcript/52746 | Identity 0.936 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/43892|m.12690 | UnnamedSample_HQ_transcript/43892 | Identity 0.940 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/43892|m.12690 | UnnamedSample_HQ_transcript/43892 | Identity 0.940 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/54688|m.14984 | UnnamedSample_HQ_transcript/54688 | Identity 0.937 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF03949 | Malic enzyme, NAD binding domain | 290 | 543 | 1.6E-97 | T | 22-09-2020 | IPR012302 | Malic enzyme, NAD-binding |
| UnnamedSample_HQ_transcript/54688|m.14984 | UnnamedSample_HQ_transcript/54688 | Identity 0.937 too low. | d7e11798ba753165af888a54979eb56d | 583 | Pfam | PF00390 | Malic enzyme, N-terminal domain | 99 | 280 | 3.3E-79 | T | 22-09-2020 | IPR012301 | Malic enzyme, N-terminal domain |
| UnnamedSample_HQ_transcript/46704|m.13301 | UnnamedSample_HQ_transcript/46704 | Coverage 0.971 too low. | f4801a337140056c0d0ee689267df47a | 401 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 2 | 180 | 1.3E-23 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/16696|m.5916 | UnnamedSample_HQ_transcript/16696 | Coverage 0.906 too low. | 3d445853d40b596535b72db0cf8d189a | 633 | Pfam | PF00595 | PDZ domain | 9 | 84 | 1.9E-5 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/85788|m.20617 | UnnamedSample_HQ_transcript/85788 | Coverage 0.897 too low. | 28148653225754e1c9dba8be05e05b4d | 240 | Pfam | PF01546 | Peptidase family M20/M25/M40 | 75 | 174 | 1.3E-26 | T | 22-09-2020 | IPR002933 | Peptidase M20 |
| UnnamedSample_HQ_transcript/20473|m.6998 | UnnamedSample_HQ_transcript/20473 | Identity 0.813 too low. | d616784e7aea6b8245b2e18bca773b54 | 881 | Pfam | PF00176 | SNF2 family N-terminal domain | 26 | 293 | 4.0E-63 | T | 22-09-2020 | IPR000330 | SNF2-related, N-terminal domain |
| UnnamedSample_HQ_transcript/20473|m.6998 | UnnamedSample_HQ_transcript/20473 | Identity 0.813 too low. | d616784e7aea6b8245b2e18bca773b54 | 881 | Pfam | PF18375 | CDH1/2 SANT-Helical linker 1 | 662 | 755 | 3.2E-37 | T | 22-09-2020 | IPR040793 | CDH1/2, SANT-Helical linker 1 |
| UnnamedSample_HQ_transcript/20473|m.6998 | UnnamedSample_HQ_transcript/20473 | Identity 0.813 too low. | d616784e7aea6b8245b2e18bca773b54 | 881 | Pfam | PF00271 | Helicase conserved C-terminal domain | 320 | 432 | 5.6E-20 | T | 22-09-2020 | IPR001650 | Helicase, C-terminal |
| UnnamedSample_HQ_transcript/45783|m.13095 | UnnamedSample_HQ_transcript/45783 | Coverage 0.985 too low. | 6413e63e9152b55d6bbe18bbe1c59869 | 413 | Pfam | PF03165 | MH1 domain | 42 | 143 | 3.7E-37 | T | 22-09-2020 | IPR003619 | MAD homology 1, Dwarfin-type |
| UnnamedSample_HQ_transcript/45783|m.13095 | UnnamedSample_HQ_transcript/45783 | Coverage 0.985 too low. | 6413e63e9152b55d6bbe18bbe1c59869 | 413 | Pfam | PF03166 | MH2 domain | 216 | 389 | 4.9E-65 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/39868|m.11823 | UnnamedSample_HQ_transcript/39868 | Identity 0.860 too low. | f55bedeb23c4e0e0db17b68dca40c65e | 707 | Pfam | PF01480 | PWI domain | 19 | 90 | 1.4E-30 | T | 22-09-2020 | IPR002483 | PWI domain |
| UnnamedSample_HQ_transcript/11767|m.4417 | UnnamedSample_HQ_transcript/11767 | Identity 0.889 too low. | 744731dd34c079a8cc9e795e8ad36605 | 380 | Pfam | PF06920 | Dock homology region 2 | 2 | 379 | 6.1E-134 | T | 22-09-2020 | IPR010703 | Dedicator of cytokinesis, C-terminal |
| UnnamedSample_HQ_transcript/7882|m.3147 | UnnamedSample_HQ_transcript/7882 | Coverage 0.682 too low. | 81dcd6c6a7e608a6a9a00d1349750349 | 526 | Pfam | PF00782 | Dual specificity phosphatase, catalytic domain | 350 | 480 | 6.1E-41 | T | 22-09-2020 | IPR000340 | Dual specificity phosphatase, catalytic domain |
| UnnamedSample_HQ_transcript/7882|m.3147 | UnnamedSample_HQ_transcript/7882 | Coverage 0.682 too low. | 81dcd6c6a7e608a6a9a00d1349750349 | 526 | Pfam | PF00581 | Rhodanese-like domain | 171 | 275 | 4.3E-7 | T | 22-09-2020 | IPR001763 | Rhodanese-like domain |
| UnnamedSample_HQ_transcript/70612|m.18036 | UnnamedSample_HQ_transcript/70612 | Coverage 0.720 too low. | 561d161bf565987ebf88276dfab930c9 | 525 | Pfam | PF00083 | Sugar (and other) transporter | 59 | 262 | 7.9E-31 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/70612|m.18036 | UnnamedSample_HQ_transcript/70612 | Coverage 0.720 too low. | 561d161bf565987ebf88276dfab930c9 | 525 | Pfam | PF00083 | Sugar (and other) transporter | 312 | 512 | 7.6E-19 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/106407|m.23386 | UnnamedSample_HQ_transcript/106407 | Coverage 0.314 too low. | 0b1f0c9b7f3d96bd5ac2b9d6a8cf6e43 | 222 | Pfam | PF02865 | STAT protein, protein interaction domain | 2 | 124 | 8.6E-37 | T | 22-09-2020 | IPR013799 | STAT transcription factor, protein interaction |
| UnnamedSample_HQ_transcript/7061|m.2882 | UnnamedSample_HQ_transcript/7061 | Coverage 0.985 too low. | 24a1bcccc6851f024ef7745e06f634f1 | 1223 | Pfam | PF00018 | SH3 domain | 1158 | 1204 | 1.2E-11 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/7061|m.2882 | UnnamedSample_HQ_transcript/7061 | Coverage 0.985 too low. | 24a1bcccc6851f024ef7745e06f634f1 | 1223 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 1026 | 1112 | 9.0E-16 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/8894|m.3480 | UnnamedSample_HQ_transcript/8894 | Coverage 0.913 too low. | 24a1bcccc6851f024ef7745e06f634f1 | 1223 | Pfam | PF00018 | SH3 domain | 1158 | 1204 | 1.2E-11 | T | 22-09-2020 | IPR001452 | SH3 domain |
| UnnamedSample_HQ_transcript/8894|m.3480 | UnnamedSample_HQ_transcript/8894 | Coverage 0.913 too low. | 24a1bcccc6851f024ef7745e06f634f1 | 1223 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 1026 | 1112 | 9.0E-16 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 8.0E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 242 | 260 | 0.062 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 723 | 742 | 0.0045 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.018 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 199 | 218 | 0.076 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF00053 | Laminin EGF domain | 415 | 459 | 2.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/19893|m.6839 | UnnamedSample_HQ_transcript/19893 | Coverage 0.730 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF00053 | Laminin EGF domain | 545 | 584 | 0.0015 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF07974 | EGF-like domain | 591 | 616 | 8.0E-5 | T | 22-09-2020 | IPR013111 | EGF-like domain, extracellular |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 242 | 260 | 0.062 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 723 | 742 | 0.0045 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 504 | 523 | 0.018 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF12661 | Human growth factor-like EGF | 199 | 218 | 0.076 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF00053 | Laminin EGF domain | 415 | 459 | 2.9E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/24154|m.7988 | UnnamedSample_HQ_transcript/24154 | Coverage 0.786 too low. | 47f16a53cdc0a865c95723054d84df27 | 901 | Pfam | PF00053 | Laminin EGF domain | 545 | 584 | 0.0015 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/105317|m.23266 | UnnamedSample_HQ_transcript/105317 | Coverage 0.987 too low. | 872ca036bae8b3ce38066a8abf05db5e | 273 | Pfam | PF00089 | Trypsin | 21 | 267 | 7.0E-46 | T | 22-09-2020 | IPR001254 | Serine proteases, trypsin domain |
| UnnamedSample_HQ_transcript/2192|m.1126 | UnnamedSample_HQ_transcript/2192 | Coverage 0.033 too low. | 4a4cd9d035cd19ec67b7c4ec08e129f6 | 1511 | Pfam | PF00169 | PH domain | 41 | 136 | 2.9E-12 | T | 22-09-2020 | IPR001849 | Pleckstrin homology domain |
| UnnamedSample_HQ_transcript/113051|m.24191 | UnnamedSample_HQ_transcript/113051 | Coverage 0.904 too low. | 02ce5acfefba5ff21671a77fe046939f | 245 | Pfam | PF02926 | THUMP domain | 139 | 241 | 5.3E-14 | T | 22-09-2020 | IPR004114 | THUMP domain |
| UnnamedSample_HQ_transcript/12534|m.4677 | UnnamedSample_HQ_transcript/12534 | Coverage 0.149 too low. | 62551229a68c6ff144ea49dae452053a | 1023 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 5 | 72 | 2.4E-21 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/12534|m.4677 | UnnamedSample_HQ_transcript/12534 | Coverage 0.149 too low. | 62551229a68c6ff144ea49dae452053a | 1023 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 787 | 990 | 2.8E-42 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/12534|m.4677 | UnnamedSample_HQ_transcript/12534 | Coverage 0.149 too low. | 62551229a68c6ff144ea49dae452053a | 1023 | Pfam | PF00702 | haloacid dehalogenase-like hydrolase | 350 | 717 | 9.2E-19 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/12534|m.4677 | UnnamedSample_HQ_transcript/12534 | Coverage 0.149 too low. | 62551229a68c6ff144ea49dae452053a | 1023 | Pfam | PF00122 | E1-E2 ATPase | 126 | 332 | 5.0E-53 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11464|m.4315 | UnnamedSample_HQ_transcript/11464 | Coverage 0.493 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF01754 | A20-like zinc finger | 495 | 517 | 1.8E-7 | T | 22-09-2020 | IPR002653 | Zinc finger, A20-type |
| UnnamedSample_HQ_transcript/11464|m.4315 | UnnamedSample_HQ_transcript/11464 | Coverage 0.493 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF02338 | OTU-like cysteine protease | 126 | 293 | 8.5E-22 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/11153|m.4209 | UnnamedSample_HQ_transcript/11153 | Coverage 0.497 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF01754 | A20-like zinc finger | 495 | 517 | 1.8E-7 | T | 22-09-2020 | IPR002653 | Zinc finger, A20-type |
| UnnamedSample_HQ_transcript/11153|m.4209 | UnnamedSample_HQ_transcript/11153 | Coverage 0.497 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF02338 | OTU-like cysteine protease | 126 | 293 | 8.5E-22 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/61910|m.16431 | UnnamedSample_HQ_transcript/61910 | Coverage 0.986 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF01754 | A20-like zinc finger | 495 | 517 | 1.8E-7 | T | 22-09-2020 | IPR002653 | Zinc finger, A20-type |
| UnnamedSample_HQ_transcript/61910|m.16431 | UnnamedSample_HQ_transcript/61910 | Coverage 0.986 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF02338 | OTU-like cysteine protease | 126 | 293 | 8.5E-22 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/12829|m.4766 | UnnamedSample_HQ_transcript/12829 | Coverage 0.483 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF01754 | A20-like zinc finger | 495 | 517 | 1.8E-7 | T | 22-09-2020 | IPR002653 | Zinc finger, A20-type |
| UnnamedSample_HQ_transcript/12829|m.4766 | UnnamedSample_HQ_transcript/12829 | Coverage 0.483 too low. | 55e6377046a5c66d8111f593eba946e6 | 523 | Pfam | PF02338 | OTU-like cysteine protease | 126 | 293 | 8.5E-22 | T | 22-09-2020 | IPR003323 | OTU domain |
| UnnamedSample_HQ_transcript/24901|m.8196 | UnnamedSample_HQ_transcript/24901 | Identity 0.880 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/13482|m.4946 | UnnamedSample_HQ_transcript/13482 | Identity 0.894 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/22494|m.7570 | UnnamedSample_HQ_transcript/22494 | Identity 0.884 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/31699|m.9878 | UnnamedSample_HQ_transcript/31699 | Coverage 0.870 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/19118|m.6615 | UnnamedSample_HQ_transcript/19118 | Identity 0.890 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/27594|m.8857 | UnnamedSample_HQ_transcript/27594 | Coverage 0.812 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/25970|m.8473 | UnnamedSample_HQ_transcript/25970 | Coverage 0.806 too low. | d3adb5cd7aa0c324e8ce25214aa2dee2 | 800 | Pfam | PF00012 | Hsp70 protein | 6 | 673 | 1.0E-168 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/32270|m.10025 | UnnamedSample_HQ_transcript/32270 | Coverage 0.520 too low. | 4fdb83485567ae984b047f533cff226f | 679 | Pfam | PF08368 | FAST kinase-like protein, subdomain 2 | 519 | 600 | 9.3E-14 | T | 22-09-2020 | IPR013579 | FAST kinase-like protein, subdomain 2 |
| UnnamedSample_HQ_transcript/69347|m.17820 | UnnamedSample_HQ_transcript/69347 | Unmapped. | 0db8251917117b0f1b4766935b8a58b6 | 326 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 5 | 268 | 2.0E-7 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/6301|m.2637 | UnnamedSample_HQ_transcript/6301 | Coverage 0.847 too low. | c4d65581c1816a289b68cc83b8335934 | 313 | Pfam | PF00069 | Protein kinase domain | 14 | 226 | 1.1E-64 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/93450|m.21726 | UnnamedSample_HQ_transcript/93450 | Coverage 0.988 too low. | 5e6be09e1fb5a49a659020a0109ab886 | 256 | Pfam | PF00151 | Lipase | 1 | 102 | 1.0E-30 | T | 22-09-2020 | IPR013818 | Lipase/vitellogenin |
| UnnamedSample_HQ_transcript/22229|m.7492 | UnnamedSample_HQ_transcript/22229 | Identity 0.777 too low. | 9b78e358810f8132558c6ef6ef92e304 | 409 | Pfam | PF00501 | AMP-binding enzyme | 75 | 402 | 1.1E-55 | T | 22-09-2020 | IPR000873 | AMP-dependent synthetase/ligase |
| UnnamedSample_HQ_transcript/12394|m.4618 | UnnamedSample_HQ_transcript/12394 | Coverage 0.941 too low. | c3bcd1007827978c3e51c7046216b4db | 828 | Pfam | PF00096 | Zinc finger, C2H2 type | 764 | 786 | 0.005 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/12394|m.4618 | UnnamedSample_HQ_transcript/12394 | Coverage 0.941 too low. | c3bcd1007827978c3e51c7046216b4db | 828 | Pfam | PF00096 | Zinc finger, C2H2 type | 736 | 758 | 0.01 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/12394|m.4618 | UnnamedSample_HQ_transcript/12394 | Coverage 0.941 too low. | c3bcd1007827978c3e51c7046216b4db | 828 | Pfam | PF00096 | Zinc finger, C2H2 type | 792 | 814 | 0.0018 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/12394|m.4618 | UnnamedSample_HQ_transcript/12394 | Coverage 0.941 too low. | c3bcd1007827978c3e51c7046216b4db | 828 | Pfam | PF00651 | BTB/POZ domain | 21 | 119 | 6.4E-23 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/72202|m.18335 | UnnamedSample_HQ_transcript/72202 | Coverage 0.805 too low. | 23da5b234db741841b2d8e2d9212fbc1 | 462 | Pfam | PF00106 | short chain dehydrogenase | 223 | 412 | 1.9E-50 | T | 22-09-2020 | IPR002347 | Short-chain dehydrogenase/reductase SDR |
| UnnamedSample_HQ_transcript/52068|m.14471 | UnnamedSample_HQ_transcript/52068 | Coverage 0.267 too low. | 6c11e6ea309ea930fbe61750ea2e61e9 | 450 | Pfam | PF09820 | Predicted AAA-ATPase | 55 | 351 | 4.8E-55 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/33989|m.10460 | UnnamedSample_HQ_transcript/33989 | Coverage 0.950 too low. | 769eb0482ddebb3223fba841a7926404 | 785 | Pfam | PF00890 | FAD binding domain | 97 | 128 | 8.8E-6 | T | 22-09-2020 | IPR003953 | FAD-dependent oxidoreductase 2, FAD binding domain |
| UnnamedSample_HQ_transcript/33989|m.10460 | UnnamedSample_HQ_transcript/33989 | Coverage 0.950 too low. | 769eb0482ddebb3223fba841a7926404 | 785 | Pfam | PF00307 | Calponin homology (CH) domain | 532 | 634 | 8.9E-16 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/19530|m.6734 | UnnamedSample_HQ_transcript/19530 | Coverage 0.042 too low. | f9f67f4a69957e75c31d1f42b154d058 | 396 | Pfam | PF14223 | gag-polypeptide of LTR copia-type | 99 | 218 | 2.4E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/52768|m.14597 | UnnamedSample_HQ_transcript/52768 | Coverage 0.986 too low. | 0f64d9cf41d9e46ddbe80cfbe55ecc7d | 196 | Pfam | PF09820 | Predicted AAA-ATPase | 2 | 189 | 1.3E-21 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/76111|m.19045 | UnnamedSample_HQ_transcript/76111 | Unmapped. | 354dea5075119176015fe1aaaed3eb7a | 409 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 6.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/90252|m.21289 | UnnamedSample_HQ_transcript/90252 | Unmapped. | 354dea5075119176015fe1aaaed3eb7a | 409 | Pfam | PF08762 | CRPV capsid protein like | 61 | 271 | 6.8E-13 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/111175|m.23983 | UnnamedSample_HQ_transcript/111175 | Coverage 0.985 too low. | 524d25e7296642ae72e7c4f8c32ad07f | 234 | Pfam | PF10453 | Nuclear fragile X mental retardation-interacting protein 1 (NUFIP1) | 211 | 234 | 1.4E-8 | T | 22-09-2020 | IPR019496 | Nuclear fragile X mental retardation-interacting protein 1, conserved domain |
| UnnamedSample_HQ_transcript/49033|m.13806 | UnnamedSample_HQ_transcript/49033 | Coverage 0.144 too low. | 42e24af09d13bc8bd3f65dfa79433424 | 399 | Pfam | PF01151 | GNS1/SUR4 family | 106 | 343 | 6.5E-67 | T | 22-09-2020 | IPR002076 | ELO family |
| UnnamedSample_HQ_transcript/116258|m.24516 | UnnamedSample_HQ_transcript/116258 | Coverage 0.489 too low. | 79b56e63864923969c414d723960238a | 232 | Pfam | PF01476 | LysM domain | 47 | 90 | 2.6E-7 | T | 22-09-2020 | IPR018392 | LysM domain |
| UnnamedSample_HQ_transcript/6314|m.2641 | UnnamedSample_HQ_transcript/6314 | Unmapped. | f250492d993a3e992cbdfecc5af8b538 | 1316 | Pfam | PF00680 | Viral RNA-dependent RNA polymerase | 950 | 1275 | 1.4E-33 | T | 22-09-2020 | IPR001205 | RNA-directed RNA polymerase, C-terminal domain |
| UnnamedSample_HQ_transcript/102348|m.22910 | UnnamedSample_HQ_transcript/102348 | Coverage 0.618 too low. | 1e65c6a37d6300233c4149f7da42f6b5 | 295 | Pfam | PF05817 | Oligosaccharyltransferase subunit Ribophorin II | 7 | 106 | 9.4E-13 | T | 22-09-2020 | IPR008814 | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit Swp1 |
| UnnamedSample_HQ_transcript/102348|m.22910 | UnnamedSample_HQ_transcript/102348 | Coverage 0.618 too low. | 1e65c6a37d6300233c4149f7da42f6b5 | 295 | Pfam | PF00151 | Lipase | 104 | 242 | 4.6E-21 | T | 22-09-2020 | IPR013818 | Lipase/vitellogenin |
| UnnamedSample_HQ_transcript/26788|m.8674 | UnnamedSample_HQ_transcript/26788 | Coverage 0.479 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/27524|m.8839 | UnnamedSample_HQ_transcript/27524 | Coverage 0.502 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/2836|m.1380 | UnnamedSample_HQ_transcript/2836 | Coverage 0.261 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/33288|m.10282 | UnnamedSample_HQ_transcript/33288 | Coverage 0.512 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/11058|m.4166 | UnnamedSample_HQ_transcript/11058 | Coverage 0.355 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/23640|m.7848 | UnnamedSample_HQ_transcript/23640 | Coverage 0.453 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/12862|m.4776 | UnnamedSample_HQ_transcript/12862 | Coverage 0.388 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/5309|m.2301 | UnnamedSample_HQ_transcript/5309 | Coverage 0.296 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/11091|m.4183 | UnnamedSample_HQ_transcript/11091 | Coverage 0.351 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/8101|m.3225 | UnnamedSample_HQ_transcript/8101 | Coverage 0.331 too low. | deb1bddba410be2ad4dcbde6365afb5b | 747 | Pfam | PF00069 | Protein kinase domain | 19 | 272 | 2.4E-72 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/33657|m.10378 | UnnamedSample_HQ_transcript/33657 | Coverage 0.458 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF12901 | SUZ-C motif | 323 | 346 | 1.8E-5 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
| UnnamedSample_HQ_transcript/33657|m.10378 | UnnamedSample_HQ_transcript/33657 | Coverage 0.458 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 78 | 140 | 2.4E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/33657|m.10378 | UnnamedSample_HQ_transcript/33657 | Coverage 0.458 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 240 | 302 | 5.9E-9 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/51270|m.14297 | UnnamedSample_HQ_transcript/51270 | Coverage 0.295 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF12901 | SUZ-C motif | 323 | 346 | 1.8E-5 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
| UnnamedSample_HQ_transcript/51270|m.14297 | UnnamedSample_HQ_transcript/51270 | Coverage 0.295 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 78 | 140 | 2.4E-8 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/51270|m.14297 | UnnamedSample_HQ_transcript/51270 | Coverage 0.295 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 240 | 302 | 5.9E-9 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/69851|m.17905 | UnnamedSample_HQ_transcript/69851 | Coverage 0.183 too low. | 7a15ce8d9e5e5785875515dacb1174b2 | 359 | Pfam | PF12901 | SUZ-C motif | 323 | 346 | 1.8E-5 | T | 22-09-2020 | IPR024642 | SUZ-C domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
